BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29593100)

  • 21. Cardiovascular Family History Increases Risk for Late-Onset Adverse Cardiovascular Outcomes in Childhood Cancer Survivors: A St. Jude Lifetime Cohort Report.
    Goldberg JF; Ness KK; Chi X; Santucci AK; Plana JC; Joshi VM; Luepker RV; Durand JB; Partin RE; Howell RM; Wilson CL; Towbin JA; Jefferies JL; Srivastava DK; Hudson MM; Robison LL; Armstrong GT
    Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):123-132. PubMed ID: 33033146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood Cancer.
    Leerink JM; van der Pal HJH; Kremer LCM; Feijen EAM; Meregalli PG; Pourier MS; Merkx R; Bellersen L; van Dalen EC; Loonen J; Pinto YM; Kapusta L; Mavinkurve-Groothuis AMC; Kok WEM
    JACC CardioOncol; 2021 Mar; 3(1):62-72. PubMed ID: 34396306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
    Kooijmans EC; Bökenkamp A; Tjahjadi NS; Tettero JM; van Dulmen-den Broeder E; van der Pal HJ; Veening MA
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008944. PubMed ID: 30855726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence of overweight in long-term survivors of childhood cancer after glucocorticoid treatment.
    Belle FN; Kasteler R; Schindera C; Bochud M; Ammann RA; von der Weid NX; Kuehni CE;
    Cancer; 2018 Sep; 124(17):3576-3585. PubMed ID: 30119140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse mental health outcomes in a population-based cohort of survivors of childhood cancer.
    Nathan PC; Nachman A; Sutradhar R; Kurdyak P; Pole JD; Lau C; Gupta S
    Cancer; 2018 May; 124(9):2045-2057. PubMed ID: 29468664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term pulmonary disease among Swiss childhood cancer survivors.
    Kasteler R; Weiss A; Schindler M; Sommer G; Latzin P; von der Weid NX; Ammann RA; Kuehni CE;
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28868646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
    Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
    JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics.
    Brignardello E; Felicetti F; Castiglione A; Chiabotto P; Corrias A; Fagioli F; Ciccone G; Boccuzzi G
    Eur J Endocrinol; 2013 Mar; 168(3):465-72. PubMed ID: 23258270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma.
    Al-Kindi SG; Abu-Zeinah GF; Kim CH; Hejjaji V; William BM; Caimi PF; Oliveira GH
    Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):748-52. PubMed ID: 26324747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician.
    Dillenburg RF; Nathan P; Mertens L
    Eur J Pediatr; 2013 Sep; 172(9):1149-60. PubMed ID: 23361962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol.
    van der Kooi ALF; Clemens E; Broer L; Zolk O; Byrne J; Campbell H; van den Berg M; Berger C; Calaminus G; Dirksen U; Winther JF; Fosså SD; Grabow D; Haupt R; Kaiser M; Kepak T; Kremer L; Kruseova J; Modan-Moses D; Ranft A; Spix C; Kaatsch P; Laven JSE; van Dulmen-den Broeder E; Uitterlinden AG; van den Heuvel-Eibrink MM;
    BMC Cancer; 2018 Sep; 18(1):930. PubMed ID: 30257669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized Massive Open Online Course for Childhood Cancer Survivors: Behind the Scenes.
    Berger C; Casagranda L; Sudour-Bonnange H; Massoubre C; Dalle JH; Teinturier C; Martin-Beuzart S; Guillot P; Lanlo V; Schneider M; Dal Molin B; Dal Molin M; Mounier O; Garcin A; Fresneau B; Clavel J; Demoor-Goldschmidt C
    Appl Clin Inform; 2021 Mar; 12(2):237-244. PubMed ID: 33763845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blunted response to a growth hormone stimulation test is associated with unfavorable cardiovascular risk factor profile in childhood cancer survivors.
    Petryk A; Baker KS; Frohnert B; Moran A; Chow L; Sinaiko AR; Steffen LM; Perkins JL; Zhang L; Hodges JS; Steinberger J
    Pediatr Blood Cancer; 2013 Mar; 60(3):467-73. PubMed ID: 23002034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
    Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring childhood cancer late effects: evidence of a healthy survivor effect.
    Asdahl PH; Ojha RP; Winther JF; Holmqvist AS; de Fine Licht S; Gudmundsdottir T; Madanat-Harjuoja L; Tryggvadottir L; Andersen KK; Hasle H;
    Eur J Epidemiol; 2017 Dec; 32(12):1089-1096. PubMed ID: 29185125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of treatment exposures on cardiovascular risk and insulin resistance in childhood cancer survivors.
    Baker KS; Chow EJ; Goodman PJ; Leisenring WM; Dietz AC; Perkins JL; Chow L; Sinaiko A; Moran A; Petryk A; Steinberger J
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1954-63. PubMed ID: 24008489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promotion of Arterial Stiffness by Childhood Cancer and Its Characteristics in Adult Long-Term Survivors.
    Arnold N; Merzenich H; Wingerter A; Schulz A; Schneider A; Prochaska JH; Göbel S; Neu MA; Henninger N; Panova-Noeva M; Eckerle S; Spix C; Schmidtmann I; Lackner KJ; Beutel ME; Pfeiffer N; Münzel T; Faber J; Wild PS
    J Am Heart Assoc; 2021 Feb; 10(5):e015609. PubMed ID: 33624513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).
    Bhakta N; Liu Q; Ness KK; Baassiri M; Eissa H; Yeo F; Chemaitilly W; Ehrhardt MJ; Bass J; Bishop MW; Shelton K; Lu L; Huang S; Li Z; Caron E; Lanctot J; Howell C; Folse T; Joshi V; Green DM; Mulrooney DA; Armstrong GT; Krull KR; Brinkman TM; Khan RB; Srivastava DK; Hudson MM; Yasui Y; Robison LL
    Lancet; 2017 Dec; 390(10112):2569-2582. PubMed ID: 28890157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.